Flexible Capital Policy Through Share Repurchases
First written in FY2017. 6 of 7 entries say "Advanced", first in FY2018-Q2. Latest entry: FY2024-Q2.
- FY2024-Q2AdvancedAnnual report
「Number of exercise-condition share acquisition rights, etc., exercised during the quarter (units) 1,600 Number of shares delivered upon exercises during the quarter (shares) 160,000 Funds raised through exercises during the quarter (¥ millions) 96」
For Series 3 share acquisition rights, 1,600 units were exercised, resulting in the delivery of 160,000 shares and the raising of ¥96 million. - FY2024-Q1AdvancedAnnual report
「Number of exercise-condition share acquisition rights, etc., exercised during the period from 1 July 2023 to 7 August 2023 (units) 1,600 Number of shares delivered upon exercises during the period from 1 July 2023 to 7 August 2023 (shares)* 160,000 Funds raised through exercises during the period from 1 July 2023 to 7 August 2023 (¥ millions) 96」
For Series 3 share acquisition rights, 1,600 units were exercised after the filing, resulting in the delivery of 160,000 shares and the raising of ¥96 million. - FY2023AdvancedAnnual report
「Proceeds of ¥7.800 million from the disposal of treasury shares upon the exercise of share acquisition rights」
13,000 shares were delivered upon the exercise of Series 3 share acquisition rights, raising ¥7.800 million. Share deliveries under the employee stock benefit program also progressed, reducing treasury shares by ¥114.442 million. - FY2023-Q3AdvancedAnnual report
「This was also attributable to the delivery of shares under the employee stock benefit program, which reduced treasury shares by ¥114.442 million, and the recording of a quarterly net loss of ¥418.826 million.」
Share deliveries under the employee stock benefit program progressed, reducing treasury shares by ¥114.442 million. - FY2022AdvancedAnnual report
「Proceeds of ¥656.551 million from the disposal of treasury shares upon the exercise of share acquisition rights」
Treasury shares were allocated to the exercise of share acquisition rights, raising ¥656.551 million. Capital policy through the disposal of treasury shares has progressed. - FY2018-Q2AdvancedAnnual report
「During the six months ended 30 September of the current fiscal year, the Company disposed of and acquired treasury shares under the trust agreements for the employee stock delivery trust and executive stock delivery trust. The disposal of treasury shares increased capital surplus by ¥721.170 million and reduced treasury shares by ¥206.487 million, while the acquisition of treasury shares increased treasury shares by ¥927.657 million.」
Disposals and acquisitions of treasury shares under the trust programs were carried out, with the acquisition of treasury shares totaling ¥927.657 million and capital surplus increasing by ¥721.170 million. - FY2017First statedAnnual report
「In practical terms, the Company also actively pursued flexible capital policy and management control, product development, targeted and flexible spending to promote sales of Red Power Serum, bonus payments with a stronger link to performance, fixed-cost reductions, effective use of assets, continued strengthening of risk management and compliance, and operation of the ISO quality management system.」
The Company pursued a flexible capital policy, including share repurchases, and recorded ¥505.251 million in cash outflows for share repurchases during the fiscal year.